Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer.
Tajima H, Okazaki M, Yamaguchi T, Ohbatake Y, Okamoto K, Nakanuma S, Terai S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Miyashita T, Takamura H, Ninomiya I, Fushida S, Ohta T.
Tajima H, et al. Among authors: terai s.
Mol Clin Oncol. 2018 Apr;8(4):623-627. doi: 10.3892/mco.2018.1579. Epub 2018 Feb 20.
Mol Clin Oncol. 2018.
PMID: 29556385
Free PMC article.